Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Evolution of the New York State Cystic Fibrosis Newborn Screening Algorithm: Two Decades of Experience.
Journal: Pediatric pulmonology
Published: January 31, 2026
Characterization of 223 infants with CFTR-related metabolic syndrome/Cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) identified during the first three years of newborn screening via IRT-DNA-SEQ in New York State.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 08, 2024
Variability in evaluation and follow-up of newborns with CRMS/CFSPID in New York State.
Journal: Pediatric pulmonology
Published: August 31, 2023
Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.
Journal: Pediatric pulmonology
Published: August 31, 2023
Changes in Body Mass Index in Children and Adolescents with Asthma during the COVID-19 Pandemic.
Journal: Pediatric allergy, immunology, and pulmonology
Published: March 24, 2023
Counseling Tobacco Smoke Exposure Reduction Measures in Pediatrics: A Quality Improvement Project.
Journal: Pediatric quality & safety
Published: January 21, 2022
The relationship between weight and pulmonary outcomes in overweight and obese people with cystic fibrosis: A retrospective observational study.
Journal: Health science reports
Published: October 01, 2021
A Pilot Study of RNA Sequencing to Improve the Diagnostic Yield of Bronchoalveolar Lavage Specimens in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Journal: Respiration; international review of thoracic diseases
Published: May 21, 2020
Transparency and diversity in cystic fibrosis research - Authors' reply.
Journal: Lancet (London, England)
Published: March 12, 2020
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
Journal: Lancet (London, England)
Published: August 24, 2019
Incidence and prevalence of common respiratory pathogens before and after implementation of the Cystic Fibrosis Foundation Infection Prevention and Control Guideline.
Journal: Journal of infection prevention
Published: March 15, 2019
Last Updated: 09/26/2026